Newsroom

MARCH 30 2021 Sean Whooley Glytec announced today that it introduced the latest version of its eGlycemic Management System (eGMS) for managing insulin. Waltham, Mass.-based Glytec’s eGMS is centered around the FDA-cleared Glucommander algorithm, which leverages real-time and historical data to recommend insulin dosing by learning each patient’s insulin sensitivity and anticipating future...

MARCH 31 2021 Amy Reyes Patients with diabetic ketoacidosis and a COVID-19 diagnosis died at increasingly higher rates than diabetic ketoacidosis patients without COVID-19, shows an analysis recently published in JAMA Network Open. Published online March 10 as a research letter, physicians led by Francisco J. Pasquel, MD, MPH, of Emory University School of Medicine, Atlanta, conducted an...

MARCH 23 2021 Medically reviewed by Michelle L. Griffith, MD — Written by Ashley Zlatopolsky Taking care of yourself is an important part of managing type 2 diabetes. It often involves making changes to your diet and lifestyle, developing a workout plan, taking your medications, and monitoring your blood sugar level throughout the day. While managing diabetes can feel overwhelming at first, a...

MARCH 10 2021 Kristen Monaco COVID-19 appeared to increase risk of mortality in people hospitalized with diabetic ketoacidosis (DKA), researchers reported. In a comparison of hospitalized DKA patients from February to September 2020, 30% of those who also had COVID-19 died in the hospital, as compared with 5% of those who didn't have COVID-19, reported Francisco Pasquel, MD, MPH, of Emory...

MARCH 10 2021 Miriam Tucker The clinical course and prognosis of individuals hospitalized with diabetic ketoacidosis (DKA) are considerably worse among those who have COVID-19, new data show. In-hospital death was sixfold greater among patients with DKA who had COVID-19 compared with those who did not, and acute kidney injury was three times more common. "These findings are worrisome and...